Professional Documents
Culture Documents
Case Presentation Hospital Case
Case Presentation Hospital Case
Case Presentation Hospital Case
◼ COUGH
HISTORY OF PRESENT ILLNESS
2 weeks prior to admission
● Mother noticed productive cough and Coryza
● Had consultation at the local health center and prescribed with Cetirizine 1mg/ml ,1 ml
once a day and Procaterol 5 Mcg/ml, 2.8ml every 12 hours and Salbutamol nebule,
nebulize every 12 hours ,which gave no relief, no other associated symptom were
present.
◼ In the interim, persistence of symptoms mother continued the medication
◼ Pneumonia during the 1st week of life, and treated for one week.
◼ No history of surgery.
◼ No known allergies to any food and medications.
◼ No other childhood like chickenpox,measles….
PRENATAL HISTORY
◼ BCG: at birth
◼ DPT: 3 doses
◼ OPV: 3 doses
◼ Hep B: 1 dose
◼ PCV: 3doses
◼ Hib:3 doses
GROWTH AND DEVELOPMENT
GROSS MOTOR :
◼ Rolled over at 4 months.
◼ Sat alone at 8 months
FINE MOTOR:
◼ Hands not fisted at 3 months.
◼ Linear scribble at 8 months.
SOCIAL DEVELOPMENT
◼ Smile responsibly at 3 months.
◼ Turns to sound at 4 months.
LANGUAGE
◼ Coos at 3 months.
able to speak dada at 9 months.
FAMILY HISTORY
◼ She was live with mother, father and 3 elder siblings and 2 helpers.
◼ Primary health giver is one of helper.
◼ Parents are financially stable.
◼ Her mother was a homemaker.
◼ Her father was running a automobile shop.
REVIEW OF SYSTEM
VITALS SIGNS:
◼ BP: not taken
◼ HR: 110bpm
◼ RR: 25cpm
◼ TEMP: 36 degree celsius
◼ O2: 99 (@ room air)
ANTHROPOMETRICS
◼ LENGTH: 76 cm
◼ WEIGHT: 9.4 kg
◼ HEAD CIRCUMFERENCE: 46 cm
◼BMI :16.3kg/m2
25
PHYSICAL EXAMINATION:
PERTINENT POSITIVE
HISTORY
PE
31
PERTINENT NEGATIVE
● FEVER
● LETHARGY
● CYANOSIS
● ANXIETY
● NASAL FLARING
● RESPIRATORY DISTRESS
● RETRACTION ( INTERCOSTAL,SUBCOSTAL,SUPRACLAVICULAR)
● TACHYCARDIA
● TACHYPNEA
● GRUNTING
● WHEEZING
● DIMINISHED BREATH SOUNDS
● RONCHI
● ABDOMINAL DISTENTION
32
DIFFERENTIAL DIAGNOSIS
1. ASTHMA
◼ RULE IN : COUGH
◼ RULE OUT: NO VOMITING,NO REFUSING TO EAT,NO POOR
WEIGHT GAIN
3.TUBERCULOSIS:
tuberculosis (TB) is an infectious disease caused by the
bacterium Mycobacterium tuberculosis. TB primarily affects the
lungs but can also affect other parts of the body, such as the
kidneys, spine, and brain
Medical order
Please admit under the service of Dr. Dechaves (PC)
Secure consent to care.
DAT, NPO for RR > 40 cpm
Monitor VS q4 hrs ; I and O q shift
IVF : D5IMB 500cc at 40 cc/hr(MR)
Labs : CBC
Chest x-ray APL,
RT-PCR -done as OPD pls attach to chart
MEDS
1. Cefuroxime 300 mg IVTT q8 hrs ( 95.7mkd)
2.Montelukast 4mg sachet 1 sachet mix with 10-20 ml
water or milk OD
3.salbutamol + ipratropium Neb 1 neb q 6 hrs
4. Cetirizine drops ,1ml 2x a day(0.26 mkd)
ROOM NO : 331, Welborn ,Paulina , 1 yr 1 month , female
HOSPITAL DAY 1 of admission, 16 days of illness:
Subjective: Objective:
Vital signs :
(-) Febrile T: 36.5
(-) Dyspnea HR:115
(-) vomiting RR:36
(-) wheezing O2 sat :95%(at room air)
(-) Diarrhea
(-) alar flaring Urine output :
(+) cough Input : 320
(+) Good suck Output :100
(+) Good intake of milk UO for 24 hr = 7.8 cc per hour
PHYSICAL EXAMINATION
General: Awake, alert and not in respiratory distress, Afebrile.
Skin: No rashes, no lesions, no laceration, no discoloration.
Head: Good hair distribution, no trauma.
Eyes- No sunken eyeballs, anicteric sclera, pupils are black, pink
palpebral conjunctiva, no conjunctivitis, no corneal opacities.
Ear- No pitting, no deformity seen, Ears are symmetrical.
Nose- Symmetrical, nasal septum in the midline without deviation, nasal
canal is patent.
Throat: Tonsils and pharynx are noted without exudate.
Mouth- Moist buccal mucosa and lips, no ulcers noted.
39
Chest& Lungs
I- No deformities,No retractions, Equal chest expansion is noted Plan :
P- No tenderness, no masses.
A- Bibasal crackles , no wheezing ● IVF D5IMB 500CC at 40 cc/hr (MR)
CVS: ● Continue medication:
I- Adynamic precordium noted. ● 1. Cefuroxime D1,D2 tom at 2pm
P- No heaves and thrills. ● 2.salbutamol + ipratropium 1 nebul q6
P- No cardiomegaly ● 3. Cetirizine drops BID
A- Regular rate, rhythm, distinct S1 and S2, no murmur noted ● 4.Montelukast OD @HS
Abdomen: ● For PPD TOMORROW
I- Flat, Soft, no visible lesions. ● Continue monitoring
A- Normoactive bowel sounds
P- No masses, bulges and tenderness, Skin turgor <2 secs.
Extremities- Warm, full pulses, CRT <2 sec.
40
LABORATORY
42
CHEST X-RAY 1
ROOM NO : 331, Welborn ,Paulina , 1 yr 1 month , female
HOSPITAL DAY 2 of admission, 17 days of illness:
Subjective : Objective
Anthropometric measurements
Height : 76 cm (z score 1)
weight :9.4 kg( z score 1)
BMI: 16.8 (underweight)
44
PHYSICAL EXAMINATIONS ASSESSMENT
Pediatric community acquired pneumonia with low risk
GENERAL : Child is awake, Active , (-)Respiratory distress, (-) Febrile
· EYES : Pupils are black( Centrally placed , sclera is white , status: improving
no coloboma seen
· EARS : no Pitting, no deformity
· NOSE: symmetrically placed , nasal septum is in midline
with no deviation ,(-) Alar flaring, Nasal canal
· CHEST AND LUNGS :
· INSPECTION :CHEST SYMMETRICALLY EXPANDING, NO
CHEST WALL DEFORMITIES, NO RETRACTIONS SEEN
· PALPATION: TACTILE FREMITUS EQUAL ON BOTH
SIDES
· AUSCULTATION: Bilateral crackles heard . R > L
· CARDIOVASCULAR : PLAN
· INSPECTION:ADYNAMIC PRECORDIUM ● cefuroxime 300 mg IV TT q8hr
· PALPATION:NO HEAVES/THRILLS HEARD ● montelukast 4mg 1 sachet mix to 10 -20 ml of water.
· AUSCULTATION :DISTINCT HEART SOUNDS HEARD
po OD
WITH NO MURMURS HEARD
· ABDOMEN : ● cetirizine drops 5 ml po BID
· INSPECTION:GLOBULAR , NO VISIBLE LESIONS ● salbutamol + ipratropium nebulization q8 hrs
· AUSCULTATION:BOWEL SOUND PRESENT WITH ● mupirocin ointment apply bid on previous iv insertion
ABSENT BRUITS site
· PALPATION:NO ABDOMINAL MASS ON LIGHT AND DEEP
PALPATION , ABDOMEN IS SOFT NO TENDERNESS
● D5IMB 500 : 40 cc/ hr
· EXTREMITIES : FULL PULSES ,CRT <2 sec , WARM ● OrderTuberculin skin test
EXTREMITIES ,NO LESIONS,NO EDEMA
LAB
tuberculin skin test is performed and waiting for results 45
ROOM NO :331 , Welborn ,Paulina , 1 yr 1 month , female
HOSPITAL DAY 3 of admission, 18 days of illness:
Subjective: Objective:
Vital sign :
12 Am:
Afebrile (+) Decreased cough Temperature: 36.0°C
(-) Diarrhea. (+) Good suck Pulse Rate: 133 bpm
(+) Good food intake Respiratory rate: 30 cpm
(+) Bowel movement x 3 O2 saturation: 98% At room air
4 AM
Temperature: 36.5°C
Pulse Rate: 136 bpm
Respiratory Rate: 28 cpm
O2 saturation: 99% at room air
8 AM
Temperature: 36.0 °C
Pulse Rate: 115 bpm
Respiratory Rate: 27 cpm
O2 Saturation: 97% at room air
12 PM
Temperature: 36.3 °C
Pulse Rate: 127 bpm
Respiratory Rate: 29 cpm
46
O2 Saturation: 98% at room air
4 PM
Temperature: 36.8°C Chest& Lungs
Pulse Rate: 138 bpm I- No deformities,No retractions, Equal chest expansion is
Respiratory Rate: 28 cpm noted
O2 Saturation: 96% at room air P- No tenderness, no masses.
A- Decreased fine crackles, no wheezing
8 PM CVS:
Temperature: 36.4 °C I- Adynamic precordium noted.
Pulse Rate: 122 bpm P- No heaves and thrills.
Respiratory Rate: 34 cpm P- No cardiomegaly
O2 Saturation: 98 % at room air A- Regular rate, rhythm, distinct S1 and S2, no murmur noted
Urine output : Abdomen:
Input : 970 I- Soft and globular, no visible lesions.
Output : 840 A- Normoactive bowel sounds
U O for 24 hr = 3.7 cc per hour P- No masses, bulges and tenderness, Skin turgor <2 secs.
Bowel movement Extremities- Warm, full pulses, CRT <2 sec.
General: Awake, alert and not in respiratory distress, Afebrile.
Skin: No rashes, no lesions, no laceration, no discoloration. Tuberculin skin test 24 (0mm
Head: Good hair distribution, no trauma.
Eyes- No sunken eyeballs, anicteric sclera, pupils are black,
no conjunctivitis, no corneal opacities.
Ear- No pitting, no deformity seen, Ears are symmetrical.
Nose- Symmetrical, nasal septum in the midline without
deviation, nasal canal is patent, Nasal congestion is noted.
Throat: Tonsils and pharynx are noted without exudate.
Mouth- Moist buccal mucosa and lips, no ulcers noted.
47
Assessment:
PLAN
48
CHEST X-RAY 2
49
ROOM NO : 331 , Welborn ,Paulina , 1 yr 1 month , female
HOSPITAL DAY 4 of admission, 19 days of illness:
SUBJECTIVE : OBJECTIVE :
51
ROOM NO : 331 , Welborn ,Paulina , 1 yr 1 month , female
HOSPITAL DAY 5 of admission, 20 days of illness:
Subjective: Objective:
53
LABORATORY FINDINGS
FECALYSIS:
PHYSICAL EXAMINATION:
- GREEN COLOR
- LOOSE CONSISTENCY
MICROSCOPIC EXAMINATION:
-NO PARASITES SEEN
-NO PUS CELLS
- NO RBC
CASE DISCUSSION
ETIOLOGY
NEONATES
<3wks
2
1
STREPTOCOCCUS MYCOPLASMA PNEUMONIA
PNEUMONIA CHLAMYDOPHILA PNEUMONIA
Most often occurs when bacteria colonize the lungs and gain
entry to the lungs
• Direct seeding of lung tissue after bacteremia
• Infection establishes in the lung parenchyma .
• S.pneumoniae: produces local edema that aids in proliferation of the
organism and their spread into adjacent areas of the lung (focal lobar
involvement)
• M.pneumonia: attaches to respiratory epithelium, inhibit ciliary action and
cellular destruction
• Group A Streptococcus: diffuse lung involvement with interstitial
pneumonia .
• S. aureus: confluent bronchopneumonia, unilateral, areas of cavitation and
necrosis
RECURRENT PNEUMONIA
•2 or more episodes in a single year or 3 or more episodes
ever, with radiographic clearing between occurrences.
• An underlying disorder should be considered if a child
experiences recurrent pneumonia
CLINICAL MANIFESTATIONS
• Upper respiratory tract infection.
• Poor feeding.
• Abrupt onset of fever.
• Restlessness
• Apprehension.
• Respiratory distress manifested as grunting;
• Nasal flaring;
• Retractions of the supraclavicular, intercostal, and
subcostal areas;
• Tachypnea;
• Tachycardia;
• Air hunger;
• Cyanosis
CLINICAL MANIFESTATIONS
● VIRAL PNEUMONIA
● Fever is usually present but temperature are lower • BACTERIAL PNEUMONIA:
than bacterial pneumonia. • High fever
● Tachypnea* • Cough
● Intercostal, subcostal and suprasternal retraction. • Chest pain
● Severe: • Others:
1. Cyanosis 1. Drowsiness with intermittent periods of
2. Lethargy restlessness.
• Crackles and wheezing 2. Tachynea*
3. Anxiety
4. Occasional delirium.
• viral vs mycoplasma pneumonia is difficult to
determine.
• BACTERIAL PNEUMONIA continue. ● ATYPICAL PNEUMONIA CAUSED BY
• Diminshed breath sounds, scattered crackles, MYCOPLASMA
rhonchi on affected lung field. ● Tachypnea
• Dullness on percussion. ● Crackles and wheezing
• A lag of expiratory excursion ● Headache
• Abdominal distension becuase of gastric dilation ● Malaise
orbileus. ● Low-grade fever.
• Abdominal pain
• Hepatomegaly
• Vomiting
• Anorexia
• Diarhhea
MANAGEMENT :
NON SEVERE PCAP, REGARDLESS OF IMMUNIZATION start Amoxicillin trihydrate at 40-50mg/kg/day Q8 for 7 days
STATUS AGAINST Streptococcus pneumoniae and /or OR at 80-90mg/kg/day Q12 for 5 to 7days.
Haemophilus influenzae type B (Hib),
start Amoxicillin-clavulanate at 80-90mg/kg/day Q12 (based on
Amoxicillin content using a 14:1 amoxicillin:clavulanate
formulation) for 5 to 7 days OR Cefuroxime at 2030mg/kg/day
Q12 for 7 days in settings with documented high-level
penicillin-resistant pneumococci or beta-lactamase-producing
H. influenzae based on local resistance data or hospital
antibiogram. (Conditional recommendation, low-grade
evidence)
severe PCAP, regardless of immunization status against start Penicillin G at 200,000 units/kg/day Q6 if with complete
Streptococcus pneumoniae, Haemophilus influenzae type b (Hib) vaccination OR Ampicillin
at 200mg/kg/day Q6 if with no or incomplete or unknown
Haemophilus influenzae type b (Hib) vaccination
72
When an atypical pathogen is highly suspected, starting a Azithromycin at 10mg/kg/day PO or IV Q24 for 5 days,
macrolide is considered as follows: particularly in infants less than 6 months old whom pertussis is
entertained, OR 10mg/kg/day Q24 for 3-5 days OR
10mg/kg/day on day 1 followed by 5 mg/kg/day Q24 for days 2
to 5
73
◼ When a specific pathogen is identified, modifying the empiric treatment based on the antibiotic susceptibility
pattern and/or the drug of choice is recommended. (Strong recommendation, high-grade evidence)
◼ When treating for uncomplicated bacterial PCAP, 7 to 10 days treatment is considered but a longer duration
may be required depending on the patient’s clinical response, virulence of the causative organism and eventual
development of complications.
74
75